Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia

Infections represent one of the most frequent complications during the treatment of patients with Acute Lymphoblastic Leukemia (ALL): of these, almost half develop an infectious event in the majority of cases in induction. The new monoclonal and bispecific antibodies and CAR-T, besides offering new...

Descripción completa

Detalles Bibliográficos
Autores principales: Quattrone, Martina, Di Pilla, Alessia, Pagano, Livio, Fianchi, Luana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885910/
https://www.ncbi.nlm.nih.gov/pubmed/36715833
http://dx.doi.org/10.1007/s10238-023-01000-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885910/
https://www.ncbi.nlm.nih.gov/pubmed/36715833
http://dx.doi.org/10.1007/s10238-023-01000-9

Ejemplares similares